Regulatory and other responses to the pharmaceutical opioid problem

Med J Aust. 2019 Jan;210(1):6-8.e1. doi: 10.5694/mja2.12047. Epub 2018 Dec 12.

Authors

Gabrielle Campbell¹, Nicholas Lintzeris^{2

3}, Natasa Gisev¹, Briony Larance^{1

4}, Sallie Pearson^{5

6}, Louisa Degenhardt¹

Affiliations

¹ National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW.
² University of Sydney, Sydney, NSW.
³ Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, NSW.
⁴ University of Wollongong, Wollongong, NSW.
⁵ Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW.
⁶ Menzies Centre for Health Policy, University of Sydney, Sydney, NSW.

No abstract available

Keywords: Analgesics, opioid; Chronic pain; Drug overdose; Opioid-related disorders; Pain management; Prescription drug misuse.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Analgesics, Opioid / adverse effects*
Australia
Drug and Narcotic Control*
Humans
Inappropriate Prescribing* / legislation & jurisprudence
Inappropriate Prescribing* / prevention & control
Opioid-Related Disorders* / prevention & control
Opioid-Related Disorders* / therapy
Prescription Drug Monitoring Programs*

Substances

Analgesics, Opioid

Grants and funding

R01 DA044170/DA/NIDA NIH HHS/United States